Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Tier II Mutagenic Screening of 13 NIOSH Priority Compounds: Individual Compound Report Cyclohexanone.

Authors
McGregor-DB
Source
NIOSH 1980 Nov:202 pages
Link
NIOSHTIC No.
00122563
Abstract
The mutagenicity of cyclohexanone (108941) was studied in a tier II mutagenic test screening program using CD-rats and B6C3F1 hybrid mice. The assays used included the unscheduled DNA synthesis (UDS) assay in human diploid fibroblasts with exposures of 3 hours (h) duration and concentrations up to 9.48 milligrams per milliliter of culture medium; the dominant lethal test in male rats following atmospheric exposure to 50 parts per million (ppm) or 400 ppm of cyclohexane for 7h per day for 5 days; sperm abnormality tests in male mice using the same exposure conditions as in the dominant lethal test; the cytogenetic test in male and female rat bone marrow cells using exposure conditions similar to the dominant lethal test or after single exposure for 7h followed by sampling after 6, 24, and 48h; and the sex linked recessieve lethal (SLRL) test in Drosophila-melanogaster after inhalation exposure to 50ppm for 7h or 400ppm for 40 minutes. There was no increase in UDS in cells treated with cyclohexanone. There were no effects attributable to cyclohexanone in the dominant lethal test and abnormal sperm frequency was not affected. There was no significant increase in chromosomal aberrations in the rat bone marrow cells and SLRL frequency was not increased in Drosophila-melanogaster. The authors conclude that cyclohexanone did not cause any observable genetic damage in these bioassays.
Keywords
NIOSH-Contract; Contract-210-78-0026; Solvents; Laboratory-animals; Screening-methods; Mutagenesis; Genetic-disorders; Biochemical-tests;
CAS No.
108-94-1;
Publication Date
19801111
Funding Type
Contract;
Fiscal Year
1981
NTIS Accession No.
PB83-127571
NTIS Price
A11
Identifying No.
Contract-210-78-0026
Source Name
NIOSH, Cincinnati, Ohio, Inveresk Research International Limited, Musselburgh, Scotland, 202 pages, 17 references
State
OH;
TOP